A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride

PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

May 28, 2013

Primary Completion Date

December 11, 2013

Study Completion Date

December 11, 2013

Conditions
Gingivitis
Interventions
DRUG

Stannous fluoride

In this arm, participants will apply a full ribbon of dentifrice ( 0.454% w/w stannous fluoride) to the bristles of a study toothbrush and brush their teeth in their usual manner for one timed minute twice daily (morning and evening) and record on their study diary completed brushings.

DRUG

Sodium monofluorophosphate

In this arm, participants will apply a full ribbon of negative control dentifrice (1000 ppm fluoride as SMFP to the bristles of a study toothbrush and brush their teeth in their usual manner for one timed minute twice daily (morning and evening) and record on their study diary completed brushings.

Trial Locations (1)

46825

GSK Investigational Site, Fort Wayne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04123665 - A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride | Biotech Hunter | Biotech Hunter